It was just two weeks ago that the World Health Organization said there haven't been any new cases of Ebola since March — but the disease that devastated an entire continent last summer could still be hiding in survivors.
A New England Journal of Medicine preliminary report found that Ebola can survive at least nine months in the semen of male survivors. This is thefirst large scale follow-up of survivors. Two-thirds of men still had Ebola in their semen up to six months after infection and a quarter of survivors still had it after nine months.But don't freak out yet — just because the genetic material is there doesn't mean they have a live virus that leads to them showing symptoms of vomiting, internal bleeding, diarrhea or possibly bleeding from the eyes. More research is needed.
But the findings show Ebola stays in the system much longer than we thought. We originally thought the virus stayed in semen for at most 82 days after victim showed symptoms. There are over 17,000 survivors.
We've known that Ebola can exist in the eyes and breast milk and semen during that period, but it wasn't thought to cause a serious health risk. During sex, males were told to always use condoms.
In total, the virus killed over 11, 300 people in West Africa.
Reuters TV examines the ramifications of the new study
65% of men (26 out of 40 tested) between four and six months
26% of men (11 out of 43 tested) between seven and nine months
Sexual transmission is "rare"
A separate study released in the same issue adds that Ebola can spread from sex with a survivor six months after they showed symptoms.The World Health Organization (WHO), who funded the study, said that sexual transmission was "rare". Large populations in Sierra Leone where high numbers of survivors live see no recurrences. The director general of WHO, Margaret Chan said:
"Does it mean they are still infectious or are they just fragments? We don't have the definitive evidence yet ... The degree of uncertainty is worrying, that's why we need to take precautionary measures, so we advise survivors to take protection through contraception."
Johnson and Johnson began clinical trials for an Ebola vaccine several days ago as the disease has no cure yet.
Main image via BBC News | Thinkstock
Advertisement
0 comments: